1. Home
  2. CORT vs FCFS Comparison

CORT vs FCFS Comparison

Compare CORT & FCFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$95.41

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Logo FirstCash Holdings Inc.

FCFS

FirstCash Holdings Inc.

HOLD

Current Price

$196.32

Market Cap

9.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CORT
FCFS
Founded
1998
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
9.7B
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
CORT
FCFS
Price
$95.41
$196.32
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$96.50
$210.67
AVG Volume (30 Days)
1.1M
441.4K
Earning Date
04-30-2026
04-23-2026
Dividend Yield
N/A
0.78%
EPS Growth
N/A
29.49
EPS
N/A
2.43
Revenue
$761,407,000.00
$3,661,043,000.00
Revenue This Year
$26.08
$16.20
Revenue Next Year
$26.98
$8.35
P/E Ratio
N/A
$81.24
Revenue Growth
12.79
8.04
52 Week Low
$28.66
$119.21
52 Week High
$97.05
$235.97

Technical Indicators

Market Signals
Indicator
CORT
FCFS
Relative Strength Index (RSI) 63.30 33.82
Support Level $76.41 $180.26
Resistance Level N/A $199.30
Average True Range (ATR) 4.17 9.15
MACD -0.36 -1.94
Stochastic Oscillator 81.02 23.34

Price Performance

Historical Comparison
CORT
FCFS

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About FCFS FirstCash Holdings Inc.

FirstCash Holdings Inc is an operator of pawn stores in the U.S., Latin America and the U.K. The company's primary line of business is the operation of retail pawn stores, also known as pawnshops. It also operates a retail POS payment solutions business. Its two business lines are organized into four reportable segments: The U.S. pawn segment consists of pawn operations in some of U.S. states and the District of Columbia; The Latin America pawn segment consists of pawn operations in Mexico, Guatemala, El Salvador and Colombia; The U.K. pawn segment consists of pawn operations in England, Scotland and Wales; and The retail POS payment solutions segment consists of the operations of American First Finance, LLC, which offers products in the U.S.

Share on Social Networks: